RNA methylation: A new promising biomaker in cancer liquid biopsy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-07 · 1880 (3) · 189337
DOI: 10.1016/j.bbcan.2025.189337 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-07. Verfasst von Chenxin Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; Colleg…. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor, RNA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 243 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
RNA methylation is a vital epigenetic modification that regulates gene expression by influencing RNA processes such as transcription, degradation, translation, and transport. Aberrant methylation, including modifications like m6A, m5C, m1A, m7G, and m3C, is closely linked to tumorigenesis and progression. Liquid biopsy, a non-invasive technique analyzing tumor markers in body fluids, offers significant potential for early diagnosis and dynamic monitoring. In this context, RNA methylation, due to its tumor-specific properties, is emerging as a valuable marker. However, significant challenges remain in its clinical application. This review explores the roles of RNA methylation in cancer, recent advances in detection technologies, and its potential as a liquid biopsy marker in tumor management. It highlights its promising applications in cancer diagnosis, prognosis, and personalized treatment in the era of precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; College of Health Science and Technology, Shanghai Jiao Tong University Scho…
- Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai J…
- Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Xu, C., Xu, X., Huang, Y., Shang, S., & Ma, L. (2025). RNA methylation: A new promising biomaker in cancer liquid biopsy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(3), 189337. https://doi.org/10.1016/j.bbcan.2025.189337
Vancouver
Xu C, Xu X, Huang Y, Shang S, Ma L. RNA methylation: A new promising biomaker in cancer liquid biopsy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(3):189337. doi:10.1016/j.bbcan.2025.189337
BibTeX
@article{Xu2025,
author = {Xu, Chenxin and Xu, Xin and Huang, Yiwen and Shang, Shuang and Ma, Lifang},
title = {RNA methylation: A new promising biomaker in cancer liquid biopsy},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {3},
pages = {189337},
doi = {10.1016/j.bbcan.2025.189337}
}
EUVIMED